Publications by authors named "Scott Friedman"

Claim this Profile
R
Real-world Comparison of Steatosis-Associated Fibrosis Estimator and Fibrosis-4 Scores for Assessing Metabolic Dysfunction-associated Steatotic Liver Disease-related Fibrosis in a Highly Diverse Urban Metabolic Dysfunction-associated Steatotic Liver Disease Population.
Xiaotao Zhang, Vikram Sivakumar, Alejandra Paredes-Marin, Asher Leviton, Augusto Villanueva, Scott L Friedman

Clin Gastroenterol Hepatol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expert Delphi consensus on surrogate endpoints for treatment assessment in metabolic dysfunction-associated steatohepatitis.
Arun J Sanyal, Atsushi Nakajima, Elisabetta Bugianesi, Giada Sebastiani, Jörn M Schattenberg, Scott L Friedman

Clin Gastroenterol Hepatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PDGFRß targeted positron emission tomography as a non-invasive biomarker for activated hepatic stellate cells: lasts steps before clinical translation.
Chittampalli N Yashaswini, Bogdan Mitran, Natalia Papadopoulos, Olivia Wegrzyniak, John Löfblom, Scott L Friedman

EJNMMI Radiopharm Chem· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identifying Environmental Factors Associated with Significant Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease/Steatohepatitis.
Alejandra Paredes-Marin, Julia Napoli, Vikram Sivakumar, Christian Near, Helen Adams, Scott L Friedman

Dig Dis Sci· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chimeric antigen receptor (CAR) T-cell therapy: Engineering immune cells to treat liver diseases.
Elmar Jaeckel, Scott L Friedman, Michael Hudecek, Ulrike Protzer

J Hepatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bridging dimensions: a comparative analysis of 2D and 3D in vitro models for hepatocellular carcinoma research.
Leticia C Valente, Luana Riechelman-Casarin, Laura L P Esteves, Gabriel P Bacil, Tereza Cristina da Silva, Scott L Friedman

Arch Toxicol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aflibercept 8 mg versus Faricimab Treat-and-Extend for Diabetic Macular Edema or Neovascular Age-Related Macular Degeneration: A Bayesian Fixed-Effect Network Meta-analysis of Clinical Trials.
Scott M Friedman, Yingxin Xu, Steven Sherman, Andreas Kuznik, Ali Mojebi

Ophthalmol Ther· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply.
Scott Friedman, Nikolas London, Jan Hamouz, Ágnes Kerényi, Andras Papp

Ophthalmol Retina· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Open Notes in Brain Injury Rehabilitation Part 1: Contrasting Perspectives of Patients and Providers.
Natalie V Covington, Scott E Friedman, Natalie Becker, Caitlin Klukas, Olivia Vruwink

Arch Phys Med Rehabil· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Open Notes in Brain Injury Rehabilitation Part 2: Provider and Patient Preferences for Artificial Intelligence Solutions.
Natalie V Covington, Scott E Friedman, Caitlin Klukas, Natalie Becker, Olivia Vruwink

Arch Phys Med Rehabil· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endothelial-to-mesenchymal transition: A targetable mechanism that contributes to portal vein thrombosis in cirrhosis.
Aina Anton, Sarah Shalaby, María Luisa Botero, Annabel Blasi, Yiliam Fundora, Scott L Friedman

Hepatology· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ACLY inhibition promotes tumour immunity and suppresses liver cancer.
Jaya Gautam, Jianhan Wu, James S V Lally, Jamie D McNicol, Russta Fayyazi, Scott L Friedman

Nature· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-VEGF Use for Conditions without US Food and Drug Administration Approval.
Ravi Parikh, Elias H Kahan, Casey Zhang, Rhiya Mittal, Arjun Watane, Scott M Friedman

Ophthalmol Retina· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resolvin D1-mediated cellular crosstalk protects against MASH.
Amaia Navarro-Corcuera, Yiwei Zhu, Fanglin Ma, Neha Gupta, Haley Asplund, Scott L Friedman

JHEP Rep· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antifibrotic therapies for metabolic dysfunction-associated steatotic liver disease.
Robert F Schwabe, Frank Tacke, Atsushi Sugimoto, Scott L Friedman

JHEP Rep· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized Trial of Biosimilar ABP 938 Compared with Reference Aflibercept in Adults with Neovascular Age-Related Macular Degeneration.
Scott Friedman, Nikolas London, Jan Hamouz, Ágnes Kerényi, Andras Papp

Ophthalmol Retina· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cannabinoid Receptor 2 Activating Antibodies: A Promising Therapeutic Strategy for Macrophage-Driven Fibro-Inflammatory Diseases.
Raghavender Reddy Gopireddy, Dipankar Bhattacharya, Swastik Sen, Monica A Schwartz, Scott L Friedman

bioRxiv· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hot and cold fibrosis: The role of serum biomarkers to assess immune mechanisms and ECM-cell interactions in human fibrosis.
Andressa de Zawadzki, Diana J Leeming, Arun J Sanyal, Quentin M Anstee, Jörn M Schattenberg, Scott L Friedman

J Hepatol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EHBP1 suppresses liver fibrosis in metabolic dysfunction-associated steatohepatitis.
Fanglin Ma, Miriam Longo, Marica Meroni, Dipankar Bhattacharya, Erika Paolini, Scott L Friedman

Cell Metab· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mannose reduces fructose metabolism and reverses MASH in human liver slices and murine models in vivo.
John G Hong, Joshaya Trotman, Yvette Carbajal, Poulomi Dey, Mariel Glass, Scott L Friedman

Hepatol Commun· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Depletion of tumor-reactive HSCs reveals their significance during different stages of liver metastasis.
Aitor Benedicto, Alba Herrero, Aritz Lopategi, Scott L Friedman, Maria Dolores Boyano

Hepatol Commun· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fat, fibrosis, and the future: navigating the maze of MASLD/MASH.
Scott L Friedman

J Clin Invest· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can we talk? The cryptic communications of hepatic stellate cells in lipid metabolism.
Scott L Friedman

Cell Metab· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advances in Extracellular Matrix-Associated Diagnostics and Therapeutics.
Morten Karsdal, Thomas R Cox, Amelia L Parker, Nicholas Willumsen, Jannie Marie Bülow Sand, Scott Friedman

J Clin Med· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo anti-FAP CAR T therapy reduces fibrosis and restores liver homeostasis in metabolic dysfunction-associated steatohepatitis.
Chittampalli N Yashaswini, Bruno Cogliati, Tianyue Qin, Tran To, Thomas Williamson, Scott L Friedman

bioRxiv· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis